Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fields, P. A.
Right arrow Articles by Fields, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fields, P. A.
Right arrow Articles by Fields, M. J.
Agricola
Right arrow Articles by Fields, P. A.
Right arrow Articles by Fields, M. J.
Biology of Reproduction 61, 527-532 (1999)
©Copyright 1999 Society for the Study of Reproduction, Inc.


Articles

B-Chain Sequence and In Situ Hybridization of the Rabbit Placental Relaxin-Like Gene Product

Phillip A. Fields1,a, Vaughan H. Leeb, Anton Jettenc, Shou-Mei T. Changd, and Michael J. Fieldsd

a Department of Structural & Cellular Biology, University of South Alabama College of Medicine, Mobile, Alabama 36688 b Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas 79430 c Cell Biology Section, Laboratory of Pulmonary Pathobiology, NIEHS, NIH, Research Triangle Park, North Carolina 27709 d Department of Animal Science, University of Florida, Gainesville, Florida 32611


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We reported that the nucleotide sequence of a cDNA generated from rabbit placental poly(A)+ RNA using porcine preprorelaxin primers was identical to SQ10, a product of squamous differentiated tracheal epithelial cells. However, these results did not confirm that SQ10 was the biologically active rabbit relaxin that had been isolated previously yet not sequenced. In this study, a 7-kDa protein isolated from rabbit placentas exhibited relaxin bioactivity and cross-reacted with a porcine relaxin antiserum. A partial amino acid sequence of this protein revealed a sequence identical to that of SQ10. Although the amino acid sequence of the putative relaxin receptor-binding domain found in the B chain of relaxin was modified in SQ10 from CGRDYVR to CRNDFVR, the placental protein was bioactive. These results suggest that SQ10 is the rabbit relaxin. In situ hybridization, using an SQ10 riboprobe, indicated radiolabeling in the syncytiotrophoblast cells of the rabbit placenta. The pattern of labeling corresponded with the immunohistochemical staining for relaxin observed with use of a porcine relaxin antiserum. These results indicate that the syncytiotrophoblast cells are a site of synthesis for SQ10 and that the immunostaining is not solely the result of sequestering SQ10 through receptor-mediated endocytosis. A potential role for relaxin in implantation is discussed.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
There is considerable evidence for the existence of relaxin in the pregnant rabbit. In 1926, Frederick Hisaw first reported relaxin bioactivity in the serum of pregnant rabbits [1]. Later, using the guinea pig pubic symphysis bioassay [2, 3] and RIA [4], serum levels of relaxin in the pregnant rabbit were shown to be present as early as the third day of gestation, to peak by Day 24, and to decline after parturition.

The placenta is a major source of relaxin in the rabbit. Placental extracts were shown to possess relaxin bioactivity [1, 5, 6], and relaxin immunostaining was demonstrated in the placental syncytiotrophoblast using antibodies to both a relaxin isolate of rabbit placenta and to porcine relaxin [5, 7]. In addition, cultured rabbit trophoblast cells were shown to undergo differentiation and transform into relaxin-containing syncytiotrophoblast that secrete relaxin [8]. However, relaxin immunostaining could not be detected in the pregnant rabbit ovary [5], and when pregnant rabbits were ovariectomized on Day 13, blood levels of relaxin were not different from those in sham controls [4]. Thus, although the ovary is the source of circulating relaxin in mammalian species such as the mouse, rat, pig, and human [9, 10], it has been ruled out as a major source of relaxin in the rabbit.

The nucleotide sequence of a preprorelaxin-like gene identified in the rabbit placenta [11] was identical to SQ10, a gene that is expressed during squamous differentiation of rabbit tracheal epithelial cells following injury [12]. Like relaxin [9, 10], SQ10 consists of an A and a B chain that are linked by two disulfide bonds [12]. The amino acid sequence of a portion of the B chain of relaxin has been conserved and represents the putative receptor-binding domain [13]. However, the amino acid sequence deduced from the nucleotide sequence of placental SQ10 [11] indicated a modification in this receptor-binding domain, and one would assume that the protein would not possess relaxin bioactivity. Since a biologically active rabbit relaxin has been isolated [1, 5, 6], the objective of this study was to determine the amino acid sequence of the B chain of a bioactive placental isolate of rabbit relaxin and to compare its sequence with that deduced from the nucleotide sequence of rabbit placental SQ10.

Relaxin has been immunohistochemically localized in rabbit placental syncytiotrophoblast [5, 7, 9]. However, these results could indicate synthesis or sequestering by receptor-mediated endocytosis. This question was addressed with in situ hybridization using a riboprobe to SQ10.

The results of these studies indicate that SQ10 is the rabbit relaxin and that the syncytiotrophoblast is a site of synthesis for this protein, suggesting a potential role for this hormone in implantation.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Tissue Extraction

Rabbit placentas, obtained from Pel-Freeze, Inc. (Roger, AR), were extracted using the procedure of Griss et al. [14]. Partially frozen placentas were homogenized with a Polytron (model no. PT1035; Brinkmann Instruments, Westbury, NY) in ice-cold extraction medium (acetone:H2O:12 N HCl, 5:2.82:0.18, v:v:v) using 5 ml/g of placenta. The procedure was modified by the addition of protease inhibitors (1 mM {alpha}-toluenesulfonyl fluoride and 10 mM EDTA, disodium salt) to the extraction medium. The homogenate was stirred for 24 h at 4°C and centrifuged at 30 000 x g for 30 min, and the precipitate was discarded. Five volumes of acetone were added to the supernatant, and this solution was stored at 4°C for 24 h. A precipitate formed and was collected by centrifugation (30 000 x g; 15 min). The precipitate was air dried and ground to a fine powder with a mortar and pestle.

Ion Exchange Chromatography

One gram of the powder was dissolved in 30 ml of column buffer (0.05 M ammonium acetate, pH 5.5) and applied to a 2.5 x 27-cm column of carboxymethyl cellulose (CM 52; Whatman, Clifton, NJ), and unbound proteins were eluted. A step-wise gradient of 0.05, 0.1, 0.3, and 0.5 M NaCl in column buffer was used to elute bound proteins. The flow rate was maintained at 1.0 ml/min. The protein eluted from each step was lyophilized, dissolved in H2O, dialyzed versus H2O, and lyophilized to a dry powder.

Western Blotting

A sample from each step of the column gradient was suspended in sample buffer (10 mM sodium phosphate [pH 7.2] and 1% SDS; with and without 5% mercaptoethanol), boiled for 1 min, and subjected to gel electrophoresis. The resolving gel consisted of 15% acrylamide (15% T, 3% Cbis) in 0.1 M sodium phosphate (pH 7.2) and 0.1% SDS. The running buffer was 0.1 M sodium phosphate (pH 7.2) and 0.1% SDS. The slab gel was run at 60 mA for 18 h and fixed in a solution of 10% acetic acid and 50% methanol. The gel was stained with 0.25% Coomassie blue in 7% acetic acid and 25% methanol and destained in 7% acetic acid and 25% methanol.

Matching sets of samples run on the same gel were not stained. Instead, these samples were electrophoretically transferred onto nitrocellulose membrane, and relaxin-immunoreactive protein bands were identified with peroxidase-antiperoxidase complex immunochemistry using antiporcine relaxin antiserum (1:250) as previously described [5].

Electroblotting and Amino Acid Sequencing

To isolate relaxin-immunoreactive protein for sequence analysis, a sample of 0.5 M NaCl eluate from the CMC (carboxymethyl cellulose) column was separated in multiple lanes on a mini-slab gel (8 x 7 x 0.075 cm) employing the Tris-tricine-SDS gel system [15]. The samples were dissolved in Laemmli's sample buffer [16] and loaded onto multiple lanes of the mini-gel (3% T, 3% Cbis stacking gel; 15% T, 3% Cbis resolving gel). The electrophoresis was carried out in Tris-tricine buffer (0.1 M Tris, 0.1 M tricine, and 0.1% SDS, pH 8.25) at 30 mA until the dye front was 1 cm from the bottom of the gel.

After separation by Tris-tricine-SDS gel, proteins were transferred electrophoretically at 70 V onto a layer of polyvinylidene difluoride (PVDF) membrane (Immobilon-PSQ; Millipore Corp., Bedford, MA) in a buffer containing 0.025 M Tris, 0.192 M glycine, 20% MeOH, pH ~8.3 [17], for 3 h at 4°C.

Proteins were visualized by staining with 0.1% Coomassie blue in 50% ethanol and 10% acetic acid for 5 min. After destaining and rinsing with distilled water, the membrane was air dried, and the protein bands of interest, i.e., bands corresponding to the reducible 7000 Mr relaxin-immunoreactive band, were excised and subjected to N-terminal amino acid sequence analysis (Protein Sequencer Model 470 A/B; Applied Biosystems, Foster City, CA) by the Protein Chemistry Core Laboratory of the interdisciplinary Center of Biotechnology Research at the University of Florida. Protein data banks were searched using the National Center for Biotechnology Information Database Search program [18].

In Situ Hybridization

Restriction enzymes, SP6 and T7 RNA polymerase, and RNase inhibitor were purchased from Promega (Madison, WI). [{alpha}-35S]UTP and x-ray film were purchased from Amersham (Arlington Heights, IL). Proteinase K and RNase-free DNase I were purchased from Boehringer-Mannheim (Indianapolis, IN). NTB-2 was purchased from Eastman Kodak Co. (New Haven, CT). All general and molecular biology grade chemicals were purchased from Fisher (Pittsburgh, PA).

Implantation sites were collected from pregnant rabbits (Day 28 of gestation) and fixed in 4% paraformaldehyde overnight. Tissues were washed with 50% ethanol and 70% ethanol three times each for 30 min at 4°C, dehydrated, and embedded in Paraplast Plus (Sherwood Medical Labs, St. Louis, MO). Paraffin wax blocks were cut at 5-µm serial sections and placed on Plus slides (Fisher). The slides were dried overnight at 37°C, placed in desiccated boxes, and stored at 4°C until used in situ hybridization.

A 473-base pair SQ10 cDNA fragment located between the XhoI and BamHI restriction sites in pCR II (Invitrogen Corp., Carlsbad, CA) was used to generate riboprobes from linearized plasmids. SQ10 riboprobes synthesized with T7 RNA polymerase were antisense and transcripts synthesized with SP6 RNA polymerase were sense. Plasmid template (1 µg) was added to polymerase reaction mix containing 50 mM NaCl; 40 mM Tris-HCl (pH 7.5); 6 mM MgCl2; 10 mM dithiothreitol; 40 mM spermidine; 0.5 mM each of ATP, CTP, and GTP; 50 µCi of [{alpha}-35S]UTP (> 1000 Ci/mmol); 60 units RNase inhibitor; and 20–70 units T7 or SP6 RNA polymerase. Reaction mix was incubated at 37°C for 1 h. DNase I (23 units) was added and incubation continued for 15 min at 37°C to digest DNA templates. [{alpha}-35S]Riboprobes were separated from unincorporated [{alpha}-35S]UTP on Bio-Rad (Richmond, CA) P30 spin columns, and probes were stored at -80°C.

Tissue sections were prepared for in situ hybridization as previously described by Lee et al. [19]. Briefly, slides were incubated with proteinase K for 30 min (37°C) and washed with PBS (4°C). Slides were incubated with 0.25% acetic anhydride in 0.1 M triethanolamine to reduce nonspecific binding, dehydrated in ethanol, and dried. 35S-Labeled riboprobes were placed on each slide (50 ng/ml) and incubated at 50°C overnight. After RNase treatment to remove unbound riboprobes, slides were dehydrated, dipped in emulsion NTB-2:distilled water (1:1) for 3 sec, and dried for 2 h. Slides were then placed in a light-tight box containing desiccant and exposed for 1–3 wk (4°C). Slides were developed with D19 (Kodak), counterstained with Mayer's hematoxylin (Sigma Chemical Co., St. Louis, MO), and coverslipped. Results were analyzed with brightfield and darkfield microscopy on an Olympus (Tokyo, Japan) BX50 microscope equipped with a 35-mm camera. Controls consisted of substitution of the sense riboprobe for the antisense riboprobe.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
A rabbit placental extract was fractionated using CMC ion-exchange chromatography, and the fractions were analyzed with SDS-PAGE. A 7-kDa protein that eluted with 0.5 M NaCl (Fig. 1, lane 9, arrow) was reducible with ß-mercaptoethanol (Fig. 1, lane 10, arrow). When the 0.5 M NaCl fraction was subjected to Western blotting analysis using antiserum to porcine relaxin, only the 7-kDa protein was immunoreactive (Fig. 2, lane 11).



View larger version (132K):
[in this window]
[in a new window]
 
FIG. 1. SDS-PAGE profile of the CMC column-eluted protein peaks. Lanes 1 and 2: Unbound fractions unreduced and reduced, respectively. Lanes 3 and 4: 0.05 M NaCl-eluted fraction unreduced and reduced. Lanes 5 and 6: 0.1 M NaCl-eluted fraction unreduced and reduced. Lanes 7 and 8: 0.3 M NaCl-eluted fraction unreduced and reduced. Lanes 9 and 10: 0.5 M NaCl-eluted fraction unreduced and reduced. Lanes 11–14: Molecular weight standards. Note in lane 9 the protein band at a molecular weight of approximately 7000 (arrow) that was reduced with mercaptoethanol (lane 10 arrow).



View larger version (100K):
[in this window]
[in a new window]
 
FIG. 2. Tris-tricine-SDS gel electrophoresis profile of the relaxin bioactive placental protein fraction eluted from the CMC column by 0.5 M NaCl after being transferred to a PVDF membrane and stained with Coomassie blue. Lanes 1–10: Coomassie blue staining. Lanes 1, 2, 9, and 10: Molecular weight standards. Lane 3: ß-Mercaptoethanol-reduced sample. Lanes 4–8: Unreduced samples. Arrows, reducible protein at 7 kDa. Lane 11: Western blot of the 0.5 M NaCl fraction using guinea pig anti-porcine relaxin serum. The reducible protein bands at approximately 7000 Mr were combined and used for amino acid sequencing.

The 7-kDa protein was electrophoretically transferred from an SDS gel to a PVDF membrane, excised, and submitted to amino acid sequencing. The sequence (Fig. 3) was identical to that deduced from the nucleotide sequence of the B chain of rabbit placental SQ10 [11]. Only 8 of 33 amino acids were identical to those in the B chain of porcine relaxin. The most significant difference between SQ10 and relaxin from 23 other species was observed in the receptor-binding domain in the B chain. In relaxin, this domain is GRXXXR, where X represents a variety of amino acids. In SQ10, this domain is RXXXXR.



View larger version (8K):
[in this window]
[in a new window]
 
FIG. 3. Amino acid sequence of the B chain of the placental isolate of rabbit relaxin-like SQ10 and porcine relaxin. Conserved amino acids in the B chain of relaxin from 23 different species are underlined. The amino acid sequence of the placental isolate of SQ10 was the same as that deduced from the nucleotide sequence of rabbit placental SQ10 [11].

Placental tissue from a Day 28 pregnant rabbit was processed for in situ hybridization using a riboprobe to SQ10. Labeling was observed in the syncytiotrophoblast of the placental villi, but it was absent over the amnion, chorion, or decidua (Fig. 4, A–D). No labeling was observed with the sense riboprobe control (Fig. 4E). The pattern of in situ hybridization labeling over the syncytiotrophoblast was similar to the pattern of immunostaining using antiserum to porcine relaxin (Fig. 4F).



View larger version (122K):
[in this window]
[in a new window]
 
FIG. 4. Day 28 rabbit implantation site. Large arrows point to the same place in panels A-E. Arrowheads: syncytiotrophoblast. A, B) Hematoxylin- and eosin-stained tissue sections. Amnion (A), chorion (C), and decidua (D). C, D) In situ hybridization using the relaxin-like SQ10 antisense riboprobe. E) Control in situ hybridization using the relaxin-like SQ10 sense riboprobe. F) Tissue incubated with guinea pig antiporcine relaxin serum. Railroad-track appearance of immunostaining in syncytiotrophoblast is similar to the in situ hybridization labeling in C and D. Bar = 120 µm in A, C, and E; 10 µm in B; 30 µm in D and F.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
A relaxin bioactive protein was isolated from rabbit placentas and subjected to N-terminal amino acid sequence analysis. The sequence of this protein was identical to that deduced from the nucleotide sequence of the B chain of rabbit placental SQ10 [11], a preprorelaxin-like protein initially shown to be produced by injured tracheobronchial epithelial cells [12].

A 7-amino acid sequence (B11 to B17) that represents the putative relaxin receptor-binding domain has been conserved in the B chain of relaxin from 23 species. This segment consists of glycine, arginine, three amino acids, and arginine. The arginines are the prongs for ligand binding [13]. The amino acid sequence of the B chain of purified rabbit placental SQ10 is arginine, four amino acids, and arginine. Although the flexibility of the receptor segment may be compromised by the loss of glycine, it may be compensated for by separating the arginines by four instead of three amino acids. Although this difference may, in part, account for the lower specific bioactivity of the rabbit relaxin as compared to porcine relaxin [5, 6], the potency of relaxin is different from species to species in which the 7-amino acid segment has been conserved. For example, rat relaxin has a lower specific activity in the mouse interpubic ligament relaxin bioassay than does porcine relaxin, and shark relaxin is inactive [9].

Our studies suggest that SQ10 is the rabbit relaxin. Polymerase chain reaction amplification of rabbit placental RNA encoding the product that hybridized with relaxin oligonucleotide probes revealed only SQ10 [11]. In this current study, the 7-kDa protein was the only immunoreactive protein band in the bioactive fraction, and there were no secondary amino acid sequences in the immunoreactive protein band used for sequencing.

The processing of SQ10 appears to be different in the trachea and in the placenta. Although there are amino acid motifs in SQ10 C peptide to A chain (arginine 151; lysine 152, 153; arginine 154) and C peptide to B chain (arginine 54) that could be cleavage sites for a trypsin-like endopeptidase, tracheal epithelial cells appear to lack a convertase necessary for processing the prohormone. Using our antibody with Western blotting, only those forms with a molecular weight similar to that of the prohormone were observed in tracheal extracts or culture medium from tracheal epithelial cells [12]. Although higher molecular weight forms of rabbit placental relaxin have been reported [20], in this current study and in previous studies [5, 6], the hormone form was observed in placental extracts.

Rabbit tracheal epithelial cells express SQ10 during the differentiation and transformation of injured pseudostratified columnar epithelial cells into stratified squamous epithelial cells and may be involved in the wound-healing process [12]. Although the role of rabbit placental SQ10 is unknown, our studies suggest a role in implantation. The in situ hybridization labeling pattern for SQ10 in syncytiotrophoblast cells, the differentiated and transformed trophoblast cells of the placental villus, was identical to the pattern observed with relaxin immunostaining using porcine relaxin antiserum. During early implantation, relaxin immunostaining has been reported also in differentiated trophoblast cells at the antimesometrial attachment sites (knob cells) and in differentiated trophoblast cells (symplasm) at the mesometrial implantation sites [21].

Relaxin promotes epithelial cell proliferation in the rat mammary gland lactiferous ducts and cervix, and it remodels connective tissue in the rat and pig uterus, mammary gland, and cervix [10]. Thus, as a product of differentiated trophoblast cells that are involved in blastocyst attachment, implantation, and placental expansion, SQ10 may act in a paracrine manner to remodel endometrial connective tissue in order to promote these processes. In addition, relaxin has been shown to promote increased vascularity in the rat cervix [22], mouse mammary gland [23], and human uteroplacenta [24]. Thus, another potential role for relaxin is to increase blood flow at the early implantation site that would support the developing fetus.


    FOOTNOTES
 
1 Correspondence: Phillip A. Fields, University of South Alabama College of Medicine, Department of Structural & Cellular Biology, MSB 1206, Mobile, AL 36688. FAX: 334 460 6771; pfields{at}usamail.usouthal.edu Back

Accepted: March 25, 1999.

Received: January 6, 1999.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Hisaw FL. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 1926; 23:661–663.[CrossRef]
  2. Abramowitz AA, Money WL, Zarrow MX, Talmage RVN, Kleinhilz LH, Hisaw FL. Preparation, biological assay and properties of relaxin. Endocrinology 1944; 34:103–114.[Abstract/Free Full Text]
  3. Marder SN, Money WL. Concentration of relaxin in the blood serum of pregnant and postpartum rabbits. Endocrinology 1944; 34:115–121.[Abstract/Free Full Text]
  4. Lee VH, Fields PA. Rabbit relaxin: the influence of pregnancy and ovariectomy during pregnancy on the plasma profile. Biol Reprod 1991; 45:209–214.[Abstract]
  5. Eldridge RK, Fields PA. Rabbit placental relaxin: purification and immunohistochemical localization. Endocrinology 1985; 117:2512–2519.[Abstract/Free Full Text]
  6. Fields PA, Larkin LH, Pardo RJ. Purification of relaxin from the placenta of the rabbit. Ann N Y Acad Sci 1982; 380:75–86.[Medline]
  7. Eldridge RK, Fields PA. Rabbit placental relaxin: ultrastructural localization in secretory granules of the syncytiotrophoblast using rabbit placental relaxin antiserum. Endocrinology 1986; 119:606–615.[Abstract/Free Full Text]
  8. Lee VH, Zhang SJ, Chang S-M T, Fields MJ, Fields PA. In vitro transformation of rabbit cytotrophoblast cells into syncytiotrophoblast: stimulation of hormone secretion by progesterone and dibutyry cyclic 3' 5'-adenosine monophosphate. Biol Reprod 1995; 52:868–877.[Abstract]
  9. Sherwood OD. Relaxin. In: Knobil E, Neill J (eds.), The Physiology of Reproduction. New York: Raven Press; 1988: 585–673.
  10. Sherwood OD. Relaxin. In: Knobil E, Neill J (eds.), The Physiology of Reproduction. New York: Raven Press; 1994: 861–1009.
  11. Fields P, Kondo S, Tashima L, Bryant-Greenwood G, Greenwood F. Expression of SQ10 (a preprorelaxin-like gene) in the pregnant rabbit placenta and uterus. Biol Reprod 1995; 53:1139–1145.[Abstract]
  12. Jetten AM, Bernacki SH, Floyd EE, Saunders NA, Pieniazek J, Reuben L. Expression of a preprorelaxin-like gene during squamous differentiation of rabbit tracheobronchial epithelial cells and its suppression by retinoic acid. Cell Growth 1992; 3:549–556.
  13. Bryant-Greenwood GD, Schwabe C. Human relaxins: chemistry and biology. Endocr Rev 1994; 15:5–26.[Abstract/Free Full Text]
  14. Griss G, Keck J, Engelhorn R, Tuppy H. The isolation and purification of an ovarian polypeptide with uterine-relaxing activity. Biochim Biophys Acta 1967; 140:45–54.
  15. Schägger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987; 166:368–379.[CrossRef][Medline]
  16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680–685.[CrossRef][Medline]
  17. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350–4354.[Abstract/Free Full Text]
  18. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984; 12:387–395.
  19. Lee VH, Lee AB, Phillips B, Roberts J, Weitlauf H. Spatio-temporal pattern for expression of Galectin-3 in the murine utero-placental complex: evidence for differential regulation. Biol Reprod 1998; 58:1277–1282.[Abstract/Free Full Text]
  20. Eldridge R, Lee V, Fields P. Isolation of multiple forms of immunoreactive relaxin-like polypeptides from rabbit placentas. In: Program of the 7th International Congress of Endocrinology; 1984; Excerpta Medica. Abstract 1224.
  21. Fields PA, Lee VH. Conceptus-mediated integrity of endometrial epithelial cells and maintenance of relaxin synthesis in pregnant rabbits: effects of unilateral oviduct ligation. Biol Reprod 1991; 44:364–374.[Abstract]
  22. Lee AB, Hwang JJ, Haab LM, Fields PA, Sherwood OD. Monoclonal antibodies specific for rat relaxin. VI. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts histological changes associated with cervical softening at parturition in rats. Endocrinology 1992; 130:2386–2391.[Abstract/Free Full Text]
  23. Bani G, Bani ST, Bigazzi M, Bianchi S. Effects of relaxin on the microvasculature of mouse mammary gland. Histol Histopathol 1988; 3:337–343.[Medline]
  24. Jauniaux E, Johnson MR, Jurkovic D, Ramsay B, Campbell S, Meuris S. The role of relaxin in the development of the uteroplacental circulation in early pregnancy. Obstet Gynecol 1994; 84:338–342.[Medline]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fields, P. A.
Right arrow Articles by Fields, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fields, P. A.
Right arrow Articles by Fields, M. J.
Agricola
Right arrow Articles by Fields, P. A.
Right arrow Articles by Fields, M. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS